SOS:NYSESOS Limited Analysis
Data as of 2026-07-23 - not real-time
$1.02
Latest Price
9/10Risk
Risk Level: High
Executive Summary
Technical outlook: SOS is trading at $1.02, just below its 20‑day SMA (1.02) and beneath both the 50‑day (1.04) and 200‑day (1.32) averages, confirming a bearish price trend. RSI sits near 49, indicating neutral momentum, while the MACD histogram turned positive, suggesting a fleeting bullish signal amid rising volume. Fundamental outlook: The company reports a 62% revenue decline, negative gross (1.5%) and operating margins (‑129%), and a trailing EPS of ‑$6.02. Cash flow is deeply negative, with operating cash outflows exceeding $246 M and free cash flow below $281 M. The balance sheet appears thin on debt but the book‑to‑price ratio is ultra‑low (PB ≈ 0.04) and the price‑to‑sales is only 0.12, reflecting a distressed valuation.
Market sentiment is in the “Extreme Greed” zone (Fear‑Greed Index 88), yet the stock’s 30‑day volatility is over 53% and beta exceeds 2.3, flagging extreme price swings. Combined with high regulatory exposure in China’s blockchain and financial‑services space, the overall risk profile is severe, making any upside highly speculative.
Market sentiment is in the “Extreme Greed” zone (Fear‑Greed Index 88), yet the stock’s 30‑day volatility is over 53% and beta exceeds 2.3, flagging extreme price swings. Combined with high regulatory exposure in China’s blockchain and financial‑services space, the overall risk profile is severe, making any upside highly speculative.
Market Outlook
Short Term
< 1 yearCautious
Model confidence: 8/10
Key Factors
- Price below key moving averages indicating continued downside
- Negative earnings and cash flow erode near‑term confidence
- High volatility and beta amplify short‑term price risk
Medium Term
1–3 yearsCautious
Model confidence: 7/10
Key Factors
- Persistently weak margins and revenue contraction
- Regulatory uncertainty around blockchain and fintech in China
- Liquidity constraints given tiny market cap and low average volume
Long Term
> 3 yearsCautious
Model confidence: 5/10
Key Factors
- Fundamental turnaround appears unlikely without major strategic shift
- Extreme drawdown history (‑87%) signals deep value erosion
- Sector and geographic risks remain elevated over the long horizon
Key Metrics & Analysis
Financial Health
Revenue Growth-62.10%
Profit Margin-63.08%
ROE-22.67%
ROA-13.01%
P/B Ratio0.0
Op. Cash Flow$-246484000
Free Cash Flow$-281035360
Industry P/E17.7
Technical Analysis
TrendBearish
RSI49.2
Support$0.93
Resistance$1.16
MA 20$1.02
MA 50$1.04
MA 200$1.32
MACDBullish
VolumeIncreasing
Fear & Greed Index88.04
Valuation
GradeUndervalued
TypeValue
Risk Assessment
Beta2.30
Volatility53.26%
Sector RiskMedium
Reg. RiskHigh
Geo RiskHigh
Currency RiskMedium
Liquidity RiskHigh
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.